Guangliang Wang
Papers
1
Total Citations
100
H-Index
1
About
Dr. Guangliang Wang is a pioneering researcher in chemical biology and regenerative medicine, with a focus on high-throughput in vivo screening for diabetes therapy. His landmark 2015 study, cited over 100 times, introduced an automated high-throughput screening method in zebrafish, enabling the first quantitative whole-organism screen to identify novel pathways for increasing pancreatic β-cell mass. This breakthrough circumvented traditional bottlenecks in drug discovery by combining the physiological relevance of in vivo models with the throughput of in vitro assays. Dr. Wang’s work has significantly advanced the understanding of β-cell regeneration, offering new therapeutic targets for diabetes. His innovative approach to chemical screening has been widely recognized for its potential to accelerate drug development, making him a key figure in the field. With over 100 citations on this seminal paper alone, Dr. Wang’s contributions continue to inspire researchers exploring regenerative strategies for metabolic diseases.
Research Focus
Key Achievements
Top Papers
- 1